Laserscope
This article was originally published in The Gray Sheet
Executive Summary
Photodynamic therapy laser system premarket approval application will be submitted in conjunction with Scotia Pharmaceuticals' NDA for the drug Foscan by September 1999 for treatment of head and neck cancer, the company says May 12. Foscan has been "fast-tracked" by FDA and could be approved by February